KAINOS LaboratoriesTSE:4556 39 Days Payable is 59.41 as of Mar. 2026, which is 22% below its 10-year median of 75.83. GuruFocus rates TSE:4556 with a GF Score™ of 39/100 and a GF Value™ of 円1,281.99 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 793 Medical Devices & Instruments companies, KAINOS Laboratories ranks worse than 55.61% on this metric.
The historical rank and industry rank for KAINOS Laboratories's Days Payable or its related term are showing as below:
TSE:4556'
s Days Payable Range Over the Past 10 Years
Min: 62.26 Med: 75.83 Max: 105.29
Current: 62.26
During the past 13 years, KAINOS Laboratories's highest Days Payable was 105.29. The lowest was 62.26. And the median was 75.83.
TSE:4556's Days Payable is ranked worse than 55.61% of 793
companies
in the Medical Devices & Instruments industry
Industry Median: 67.83
vs TSE:4556: 62.26
KAINOS Laboratories's Days Payable
declined
from Mar. 2025 (68.11) to Mar. 2026 (59.41).
It may suggest that KAINOS Laboratoriesaccelerated paying its suppliers.
KAINOS Laboratories Days Payable Related Terms
KAINOS Laboratories Days Payable Historical Data
* Premium members only.
The historical data trend for KAINOS Laboratories's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4556 vs ISRG, BDX, MDLN: Days Payable Comparison
For the Medical Instruments & Supplies subindustry, KAINOS Laboratories's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
KAINOS Laboratories Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, KAINOS Laboratories's Days Payable distribution charts can be found below:
* The bar in red indicates where KAINOS Laboratories's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
KAINOS Laboratories's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
KAINOS Laboratories (TSE:4556) has a Days Payable of 59.41 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on KAINOS Laboratories and its competitors. This is 22% below median its historical median of 75.83. Over the past decade, KAINOS Laboratories' Days Payable has ranged from 62.26 to 105.29. According to the industry distribution chart, KAINOS Laboratories ranks #441 out of 793 companies in the Medical Devices & Instruments industry, placing it in the top 55.6%.
Is KAINOS Laboratories' Days Payable too high?
KAINOS Laboratories' current Days Payable of 59.41 is 22% below median its 10-year median of 75.83. Over the past 10 years, this metric has ranged from a low of 62.26 to a high of 105.29. The Medical Devices & Instruments industry median Days Payable is 67.83. KAINOS Laboratories' value of 59.41 is 12.4% below this industry median. Based on the distribution chart, KAINOS Laboratories ranks #441 out of 793 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, KAINOS Laboratories has a GF Score™ of 39/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does KAINOS Laboratories' Days Payable compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, KAINOS Laboratories ranks #441 out of 793 companies for Days Payable. This places KAINOS Laboratories in the lower half of its industry. The industry median Days Payable is 67.83. KAINOS Laboratories' value of 59.41 is 12.4% below this benchmark. Historically, KAINOS Laboratories' own Days Payable has ranged from 62.26 to 105.29 over the past decade. While the company's 10-year median is 75.83 vs. the industry median of 67.83, KAINOS Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 67.83, based on 793 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. KAINOS Laboratories's current Days Payable of 59.41 is 12.4% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on KAINOS Laboratories and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 67.83 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. KAINOS Laboratories's current Days Payable is 59.41, which is 22% below median its own 10-year median of 75.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is KAINOS Laboratories stock overvalued right now?
Based on GuruFocus' analysis, KAINOS Laboratories (TSE:4556) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,281.99, compared to a current price of 円2,268.00 — trading 76.9% above its estimated fair value. The current Days Payable is 59.41, which is 22% below median its 10-year median of 75.83 and 12.4% below the Medical Devices & Instruments industry median of 67.83. KAINOS Laboratories' overall GF Score™ is 39/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For KAINOS Laboratories (TSE:4556), the current Days Payable is 59.41 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is KAINOS Laboratories (TSE:4556) Overvalued in 2026?
Based on GuruFocus' analysis, KAINOS Laboratories stock appears to be overvalued.
The current stock price of 円2,268.00 is trading 76.9% above its estimated GF Value™ of 円1,281.99.
GuruFocus considers KAINOS Laboratories to be Significantly Overvalued.
Key valuation signals for TSE:4556:
Days Payable: 59.41 (22% below median its 10-year median of 75.83)
GF Value™: 円1,281.99 vs. price of 円2,268.00 (76.9% above fair value)
Industry Position: 12.4% below the Medical Devices & Instruments median (#441 of 793)
No single metric tells the full story. See the TSE:4556 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
KAINOS Laboratories Inc is focused on the development, manufacture, marketing, distribution, and import/export of pharmaceuticals, diagnostic reagents, and related chemical products. It also manufactures, sells, and exports/imports physicochemical measuring equipment for medical use.
39GF Score
Get the complete analysis for TSE:4556
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4556 has been successfully added to your 
